FDA Approves Bristol Myers Squibb’s CAR T Cell Therapy Lymphoma Treatment

The cell therapy will be manufactured for each individual patient at BMS’ immunotherapy manufacturing facility in Bothell, WA, and will be launched across a network of treatment centers.